We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VFC icon
1176
VF Corp
VFC
$5.4B
$205K ﹤0.01%
15,199
-22,058
-59% -$289K
ABM icon
1177
ABM Industries
ABM
$2.77B
$204K ﹤0.01%
+4,042
New +$189K
NAVI icon
1178
Navient
NAVI
$897M
$203K ﹤0.01%
13,944
+1,440
+12% +$22.3K
SFBS
1179
ServisFirst Bancshares
SFBS
$4.72B
$202K ﹤0.01%
6,400
+200
+3% +$6.17K
EAT icon
1180
Brinker International
EAT
$10B
$202K ﹤0.01%
+2,785
New +$166K
TPG icon
1181
TPG
TPG
$9.05B
$201K ﹤0.01%
4,845
+105
+2% +$4.49K
TXG icon
1182
10x Genomics
TXG
$8.23B
$199K ﹤0.01%
10,213
-1,418
-12% -$37.1K
JELD icon
1183
JELD-WEN Holding
JELD
$201M
$198K ﹤0.01%
+14,708
New +$246K
RUN icon
1184
Sunrun
RUN
$2.15B
$198K ﹤0.01%
16,675
+3,361
+25% +$41.2K
OSCR icon
1185
Oscar Health
OSCR
$9.39B
$195K ﹤0.01%
+12,300
New +$226K
FULT icon
1186
Fulton Financial
FULT
$4.53B
$193K ﹤0.01%
+11,345
New +$184K
BGC icon
1187
BGC Group
BGC
$5.75B
$192K ﹤0.01%
23,184
+1,441
+7% +$11.9K
BXMT icon
1188
Blackstone Mortgage Trust
BXMT
$2.32B
$192K ﹤0.01%
11,034
+533
+5% +$9.62K
BNL icon
1189
Broadstone Net Lease
BNL
$4.34B
$189K ﹤0.01%
11,922
+580
+5% +$8.78K
FOLD
1190
DELISTED
Amicus Therapeutics
FOLD
$184K ﹤0.01%
18,555
+936
+5% +$9.61K
ZETA icon
1191
Zeta Global
ZETA
$7.63B
$183K ﹤0.01%
+10,377
New +$152K
MP icon
1192
MP Materials
MP
$10.1B
$182K ﹤0.01%
14,298
-1,427
-9% -$22.4K
HL icon
1193
Hecla Mining
HL
$13.7B
$178K ﹤0.01%
36,696
-169
-0.5% -$902
SITC icon
1194
SITE Centers
SITC
$157M
$175K ﹤0.01%
15,468
+698
+5% +$7.68K
LXP icon
1195
LXP Industrial Trust
LXP
$3.6B
$169K ﹤0.01%
3,701
+175
+5% +$7.66K
GNW icon
1196
Genworth Financial
GNW
$3.76B
$169K ﹤0.01%
27,927
+383
+1% +$2.38K
DAN icon
1197
Dana Inc
DAN
$3.27B
$169K ﹤0.01%
13,906
-870
-6% -$11.3K
ABR icon
1198
Arbor Realty Trust
ABR
$940M
$168K ﹤0.01%
11,726
+468
+4% +$6.26K
UAA icon
1199
Under Armour
UAA
$2.2B
$168K ﹤0.01%
25,182
-6,422
-20% -$43.8K
BUR icon
1200
Burford Capital
BUR
$946M
$166K ﹤0.01%
+12,698
New +$186K

Similar funds

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.